1. Home
  2. FTRE

as of 08-05-2026 3:46pm EST

$19.07
+$1.08
+5.98%
Stocks Health Care Medical Specialities Nasdaq

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Founded: 1996 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 1.3B IPO Year: 2023
Target Price: $14.06 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.39 EPS Growth: -194.55
52 Week Low/High: $6.07 - $21.39 Next Earning Date: 05-05-2026
Revenue: $2,723,400,000 Revenue Growth: 1.00%
Revenue Growth (this year): -2.66% Revenue Growth (next year): 3.09%
P/E Ratio: -46.13 Index: N/A
Free Cash Flow: 88.3M FCF Growth: -62.79%

AI-Powered FTRE Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 77.10%
77.10%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Fortrea Holdings Inc. (FTRE)

Sell
FTRE Aug 3, 2026

Avg Cost/Share

$18.01

Shares

9,700

Total Value

$174,697.00

Owned After

36,399

SEC Form 4

Morais Mark A.

Chief Operating Officer

Sell
FTRE Jun 10, 2026

Avg Cost/Share

$16.82

Shares

4,674

Total Value

$78,616.68

Owned After

71,365

SEC Form 4

Mcconnell Jill G.

Chief Financial Officer

Sell
FTRE Jun 2, 2026

Avg Cost/Share

$15.49

Shares

4,866

Total Value

$75,374.34

Owned After

78,416

SEC Form 4

Morais Mark A.

Chief Operating Officer

Sell
FTRE Jun 2, 2026

Avg Cost/Share

$15.49

Shares

4,866

Total Value

$75,374.34

Owned After

71,365

SEC Form 4

Parks Robert

Chief Accounting Officer

Sell
FTRE May 18, 2026

Avg Cost/Share

$13.44

Shares

2,000

Total Value

$26,880.00

Owned After

20,389

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q2

Q2 2026 Earnings

8-K BUY

Jul 29, 2026 · 100% conf.

AI Prediction BUY

1D

+6.63%

$21.75

Act: -6.47%

5D

+8.22%

$22.08

20D

+15.99%

$23.66

Price: $20.40 Prob +5D: 100% AUC: 1.000
0001628280-26-050368

EX-99.1

2 exhibit991-pressreleasedat.htm

EX-99.1

Document

Exhibit 99.1

Fortrea Reports Second Quarter 2026 Results

Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance

Highlights

For the three months ended June 30, 2026:

•Revenues of $678.2 million

•Book-to-bill ratio of 1.06x, resulting in 1.12x book-to-bill for the trailing 12 months

•GAAP net loss of $(13.2) million, or $(0.14) per diluted share

•Adjusted EBITDA of $58.7 million

•Adjusted net income of $22.7 million, or $0.23 per diluted share

•Cash provided by operations of $28.9 million and free cash flow of $19.9 million

•Full-year 2026 guidance increased to revenue of $2,620 million to $2,690 million and adjusted EBITDA of $205 million to $220 million

DURHAM, N.C., July 29, 2026— Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today reported financial results for the second quarter ended June 30, 2026.

"Our second quarter results reflect continued progress against our strategy and disciplined execution across the business," said Anshul Thakral, CEO of Fortrea. "We delivered solid operating and financial performance, including our fourth consecutive quarter with a book-to-bill ratio above 1.0x, and raised our full-year 2026 guidance to reflect our confidence in the business. Underlying this performance is the dedication of our teams around the world, who continue to build trusted partnerships with clients and help advance important therapies for patients. We remain focused on commercial execution, operational excellence and financial discipline as we continue our strategic journey toward sustainable growth and margin expansion."

Second Quarter 2026 Financial Results

Revenue for the second quarter was $678.2 million, compared to $710.3 million in the second quarter of 2025.

Second quarter GAAP net loss was $(13.2) million and diluted loss per share was $(0.14), compared to second quarter of 2025 GAAP net loss of $(374.9) million and diluted loss per share of $(4.14), inclusive of a non-cash goodwill impairment charge of $309.1 million. Second quarter adjusted net income was $22.7 million and adjusted diluted EPS was $0.23 compared to second quarter of 2025 adjusted net income of $17.6 million and adjusted diluted EPS of $0.19. Second quarter adjusted EBITDA was $58.7 million, compared to second quarter of 2025 adjusted EBITDA of $54.9 million.

Backlog as of June 30, 2026 was $7,800 million, and the book-to-bill ratio for the quarter was 1.06x.

First Half 2026 Financial Results

Revenue for the first half was $1,314.7 million, compared to $1,361.6 million in the first half of 2025.

First half GAAP net loss was $(36.8) million and diluted loss per share was $(0.39), compared to first half of 2025 GAAP net loss of $(937.8) million and diluted loss per share of $(10.37), inclusive of a non-cash goodwill impairment charge of $797.9 million. First half adjusted net income was $37.9 million and adjusted diluted EPS was $0.38 compared to first half of 2025 adjusted net income of $19.5 million and adjusted diluted EPS of $0.21. First half adjusted EBITDA was $105.7 million, compared to first half of 2025 adjusted EBITDA of $85.2 million.

2026 Financial Guidance

The Company increased its guidance for the full-year 2026, targeting revenues in the range of $2,620 million to $2,690 million and adjusted EBITDA in the range of $205 million to $220 million.

Earnings Call and Replay

Fortrea will host a conference call at 8:00 am ET on July 29, 2026, to review its second quarter financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea website. A supplemental slide presentation will also be available on the Investor Relations website prior to the start of the call.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile

2026
Q1

Q1 2026 Earnings

8-K BUY

May 5, 2026 · 100% conf.

AI Prediction BUY

1D

+6.43%

$15.46

Act: +7.64%

5D

+9.76%

$15.95

Act: +0.55%

20D

+17.68%

$17.10

Act: +7.57%

Price: $14.53 Prob +5D: 100% AUC: 1.000
0001628280-26-030101

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1784726519.7ff1d7a

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 26, 2026 · 100% conf.

AI Prediction BUY

1D

+6.43%

$11.49

Act: -2.36%

5D

+9.76%

$11.85

Act: -8.15%

20D

+17.68%

$12.71

Price: $10.80 Prob +5D: 100% AUC: 1.000
0001628280-26-011942

ftre-202602260001965040FALSE00019650402026-02-262026-02-260001965040us-gaap:CommonClassAMember2026-02-262026-02-260001965040us-gaap:PreferredClassAMember2026-02-262026-02-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

February 26, 2026 (Date of earliest event reported)

Fortrea Holdings Inc. (Exact Name of Registrant as Specified in its Charter)

Delaware 001-4170492-2796441

(State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

8 Moore Drive

Durham, North Carolina 27713 (Address of principal executive offices) (Zip Code)

(Registrant’s telephone number including area code) 877-495-0816

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act.

Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.001 par valueFTREThe NASDAQ Stock Market LLC Rights to Purchase Series A Preferred Stock, par value $0.001 per share-The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On February 26, 2026, Fortrea Holdings Inc. (the “Company”) issued a press release, announcing the Company's financial results for the year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.

Item 9.01 - Financial Statements and Exhibits (d) Exhibits

Exhibit No.Description 99.1 Press Release issued by the Company dated February 26, 2026

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Fortrea Holdings Inc. By: /s/ Jill McConnell

Name: Jill McConnell Title: Chief Financial Officer

Date: February 26, 2026

Share on Social Networks: